RMRina Mitsuya

Rina Mitsuya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rina Mitsuya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Akira Kato

    The Institutes of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan

    1 shared publication
  • Atsushi Natsume

    The Institutes of Innovation for Future Society, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan

    1 shared publication
  • Keisuke Imaeda

    Department of Chemistry, Faculty of Science, Hokkaido University, Kita 10, Nishi 8, Kita-ku, Sapporo, Hokkaido 060-0810, Japan

    1 shared publication
  • Kiichi Sato

    Graduate School of Science and Technology, Gunma University, Tenjin-cho, Kiryu 376-8515, Gunma, Japan

    1 shared publication
  • Kimiko Inoue

    Department of Chemistry, Faculty of Science, Hokkaido University, Sapporo 060-0810, Hokkaido, Japan

    1 shared publication
  • Koki Kunitake

    Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan

    1 shared publication

Latest Publications

  • Open Access

    Glomerular routing of tumor-derived extracellular vesicles substantiates urinary biopsy

    by Shota Kawaguchi, Taiga Ajiri, Rina Mitsuya, Reiko Tsuchiya, Koki Kunitake, Yoshikazu Tanaka, Takeshi Yokoyama, Kiichi Sato, Yusuke Sato, Zetao Zhu, et al.

    Urinary small extracellular vesicles (sEVs), which can reflect systemic conditions, hold great promise for noninvasive cancer diagnostics, yet the mechanism by which tumor-derived sEVs reach urine remains unclear. Here, we demonstrate that the glomerulus actively transcytoses circulating tumor-derived sEVs into urine. Using CRISPR guide RNA–tagged glioma sEVs and bioluminescent/fluorescent green-enhanced nano-lantern (GeNL)–tagged lung and pancreatic cancer sEVs, we tracked their journey from tumors to urine in multiple mouse models. In vivo and in vitro analyses revealed endocytic uptake and transcytotic release by glomerular cells, accompanied by changes in sEV size and surface composition. GeNL-tagged sEVs consistently showed higher signals in urine than plasma, indicating selective excretion. These findings redefine the glomerulus as a dynamic regulator of sEV processing and establish a mechanistic foundation for urinary liquid biopsy.